Data / New clinical trials / Irritable Bowel Syndrome
Irritable Bowel Syndrome trials: 144 new since Nov 2024
The full list. New Irritable Bowel Syndrome clinical trials: 144 rows for $7.20, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 6 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/irritable-bowel-syndrome, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
144 clinical studies in Irritable Bowel Syndrome were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 12 have an industry sponsor and 100 are recruiting or about to. The newest, NCT07926945, was posted on November 9, 2026: Effects of nVNS on Stress Reactivity in IBS (University of California, Los Angeles).
The request: Every new Irritable Bowel Syndrome clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 144New trials
- 12Industry sponsored
- 100Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 144, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926945 | Effects of nVNS on Stress Reactivity in IBS | University of California, Los Angeles | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 200 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922668 | Abdominal Symptoms and Rosacea: An Observational Study on the Association Between Irritable Bowel Syndrome (IBS) and the Gut-Skin Axis | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | IBS (Irritable Bowel Syndrome), Rosacea | 300 | Italy | clinicaltrials.gov |
| November 4, 2026 | NCT07916948 | Effects of Epetôme on Gastrointestinal Function, Inflammation and Wellbeing in Adults With IBS-like Symptoms (EPEGUT) | University of Roehampton | Not applicable | Not yet recruiting | IBS - Irritable Bowel Syndrome, Gastrointestinal Motility Disorder | 60 | United Kingdom | clinicaltrials.gov |
| November 4, 2026 | NCT07916688 | Lactic Acid Bacteria in Functional Diarrheal Disorders | Szeged University | Not applicable | Recruiting | IBS-D (Diarrhea-predominant), IBS (Irritable Bowel Syndrome), Functional Diarrhea | 100 | Hungary | clinicaltrials.gov |
| November 3, 2026 | NCT07914478 | Role of Vitamin D Supplementation in Children With Irritable Bowel Syndrome | Aziz Bhatti Shaheed Teaching Hospital | Not applicable | Recruiting | Irritable Bowel Syndrome (IBS), Vitamin D Deficiency | 48 | Pakistan | clinicaltrials.gov |
| October 29, 2026 | NCT07902882 | A Clinical Trial to Examine the Effects of Gut Health Supplements to Improve Gut and Digestive Health and Function | JS Health & Vitamins | Not applicable | Completed | Bloating, Digestive Discomfort, Irritable Bowel Syndrome (IBS), Flatulence, Constipation, Gut Health | 60 | United States | clinicaltrials.gov |
| October 28, 2026 | NCT07901972 | Nutritional Management of the Irritable Bowel Syndrome(IBS): The Role of the Mediterranean Diet (MD) | University Hospital of Patras | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 108 | clinicaltrials.gov | |
| October 23, 2026 | NCT07890948 | NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED, SINGLE-BLIND... | Hoag Memorial Hospital Presbyterian | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 40 | clinicaltrials.gov | |
| October 20, 2026 | NCT07882953 | SIMBA in Irritable Bowel Syndrome (IBS) | University of Calgary | Phase 1 | Not yet recruiting | Irritable Bowel Syndrome (IBS), Microbiome | 180 | Canada | clinicaltrials.gov |
| October 19, 2026 | NCT07880327 | Psyllium Husk in Pediatric IBS | Eman ElHaddad | Not applicable | Not yet recruiting | Prebiotic, IBS (Irritable Bowel Syndrome), Psyllium, Quality of Life (QOL) | 70 | clinicaltrials.gov | |
| October 13, 2026 | NCT07872514 | Personalized Probiotic Treatments for Irritable Bowel Syndrome | McMaster University | Not applicable | Enrolling by invitation | Irritable Bowel Syndrome (IBS) | 30 | Canada | clinicaltrials.gov |
| October 13, 2026 | NCT07870915 | Relationship Between Interoception and Postural Control in Constipation-Predominant Irritable Bowel Syndrome | Saglik Bilimleri Universitesi | Observational | Recruiting | Constipation, Irritable Bowel Disease | 128 | Turkey (Türkiye) | clinicaltrials.gov |
| October 5, 2026 | NCT07856823 | High-Resolution Measurements of Diet-Microbiome Interactions | Stanford University | Not applicable | Not yet recruiting | IBS (Irritable Bowel Syndrome) | 40 | United States | clinicaltrials.gov |
| October 1, 2026 | NCT07852819 | Interactive Effects of Early-Life Stress, Diet, and Metabolism on Gastrointestinal Dysfunction With Neuropsychiatric Symptoms | Shandong University | Observational | Not yet recruiting | Irritable Bowel Syndrome (IBS), Functional Dyspepsia, Inflammatory Bowel Disease (IBD), Gastroparesis, Depressive... | 200 | clinicaltrials.gov | |
| September 21, 2026 | NCT07829666 | Short-Term Effects of Low-FODMAP, NICE Dietary Advice, and Intermittent Fasting in Irritable Bowel Syndrome | Acibadem University | Not applicable | Completed | Irritable Bowel Syndrome | 90 | Turkey (Türkiye) | clinicaltrials.gov |
| September 2, 2026 | NCT07800650 | Low-FODMAP vs Gluten-Free Diet in Irritable Bowel Syndrome | Ertuğrul Çoruh | Not applicable | Completed | Irritable Bowel Syndrome | 70 | Turkey (Türkiye) | clinicaltrials.gov |
| September 1, 2026 | NCT07797998 | Association of Diet and IBD | Assiut University | Observational | Not yet recruiting | IBD, Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 100 | Egypt | clinicaltrials.gov |
| August 28, 2026 | NCT07793487 | Applications of a Functional Dairy Product in Diet Therapy | Warsaw University of Life Sciences | Not applicable | Enrolling by invitation | Metabolic Syndrome, IBS - Irritable Bowel Syndrome | 80 | Poland | clinicaltrials.gov |
| August 19, 2026 | NCT07774923 | Dietary Interventions for Irritable Bowel Syndrome | Istanbul Gelisim University | Not applicable | Completed | Irritable Bowel Syndrome | 60 | Turkey (Türkiye) | clinicaltrials.gov |
| August 17, 2026 | NCT07768267 | Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome | Johns Hopkins University | Phase 2 | Enrolling by invitation | Irritable Bowel Syndrome (IBS), Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | 40 | United States | clinicaltrials.gov |
| August 12, 2026 | NCT07760298 | Calisthenics Versus Cycling Exercises on Interleukin-6 and Quality of Life in Benha University Students With Irritable Bowel Syndrome | Cairo University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 60 | clinicaltrials.gov | |
| August 6, 2026 | NCT07750535 | Liver Steatosis and Fibrosis in Non-Celiac Wheat Sensitivity Patients: a Prospective Study | University of Palermo | Observational | Recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Non Celiac Wheat Sensitivity, Irritable Bowel Syndrome... | 250 | Italy | clinicaltrials.gov |
| July 23, 2026 | NCT07722572 | Low-FODMAP vs Lactose-Gluten-Free Diet in Patients With Irritable Bowel Syndrome | Antalya Bilim University | Not applicable | Completed | Irritable Bowel Syndrome | 72 | Turkey (Türkiye) | clinicaltrials.gov |
| July 21, 2026 | NCT07716852 | Enzymax DuoBiotics for Irritable Bowel Syndrome | Gala Servicios Clinicos S.L. | Not applicable | Not yet recruiting | Irritable Bowel Syndrome, Irritable Bowel Syndrome (IBS) | 120 | clinicaltrials.gov | |
| July 16, 2026 | NCT07707635 | IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel Syndrome | Ariel University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 150 | clinicaltrials.gov | |
| July 13, 2026 | NCT07699926 | Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome | My Myracle Sdn.Bhd | Not applicable | Completed | IBS (Irritable Bowel Syndrome), IBD (Inflammatory Bowel Disease), Gut Health | 55 | Malaysia | clinicaltrials.gov |
| July 9, 2026 | NCT07693907 | A Taiwan-Adapted Self-Management Program for Adults With Irritable Bowel Syndrome | National Defense Medical Center, Taiwan | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 54 | clinicaltrials.gov | |
| July 7, 2026 | NCT07688044 | The Role That Food and Bacteria Play in Generating Abdominal Pain | David Reed | Not applicable | Recruiting | Irritable Bowel Syndrome (IBS) | 60 | Canada | clinicaltrials.gov |
| June 30, 2026 | NCT07676136 | A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients | Stanford University | Not applicable | Not yet recruiting | Disorders of Gut-brain Interaction, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome, Abdominal Pain... | 26 | United States | clinicaltrials.gov |
| June 23, 2026 | NCT07662083 | Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C | West Virginia University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS-C) | 80 | United States | clinicaltrials.gov |
| June 18, 2026 | NCT07656623 | Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress | Institute of Gastroenterology and Hepatology, Vietnam | Not applicable | Recruiting | Irritable Bowel Syndrome With Diarrhea | 60 | Vietnam | clinicaltrials.gov |
| June 17, 2026 | NCT07655375 | Study Evaluating the Effect of UCB8600 on Mast Cell Activation in the Human Gut | Guy Boeckxstaens | Not applicable | Recruiting | IBS (Irritable Bowel Syndrome) | 60 | Belgium | clinicaltrials.gov |
| June 15, 2026 | NCT07646834 | Anxiety and Depression in IBS: A Brain-Gut Axis Study | Tang-Du Hospital | Observational | Recruiting | Irritable Bowel Syndrome (IBS), Anxiety, Depression | 200 | China | clinicaltrials.gov |
| June 9, 2026 | NCT07635394 | Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome | Beijing Tiantan Hospital | Not applicable | Recruiting | Irritable Bowel Syndrome (IBS) | 258 | China | clinicaltrials.gov |
| June 2, 2026 | NCT07619573 | EFFECT OF A DİETİTİAN-SUPERVİSED LOW-FODMAP DİET VERSUS STANDARD WRİTTEN ADVİCE ON GASTROİNTESTİNAL SYMPTOMS AND INFLAMMATORY BİOMARKERS İN... | Biruni University | Not applicable | Completed | Irritable Bowel Syndrome (IBS) | 50 | Turkey (Türkiye) | clinicaltrials.gov |
| May 26, 2026 | NCT07607132 | Digitally Delivered Dietary Treament for Adult Patients With Irritable Bowel Syndrome: A Pilot Study | Sahlgrenska University Hospital | Not applicable | Completed | Irritable Bowel Syndrome | 32 | Sweden | clinicaltrials.gov |
| May 20, 2026 | NCT07600047 | A Well-Being Intervention for People With IBS | University of Wisconsin, Madison | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 150 | United States | clinicaltrials.gov |
| May 15, 2026 | NCT07591584 | A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With... | Kiwi Health Inc | Not applicable | Recruiting | IBS (Irritable Bowel Syndrome), Bloating, Abdominal Pain, Gut Health | 150 | United States | clinicaltrials.gov |
| May 13, 2026 | NCT07584473 | NCWS or IBS/FD in Relatives of CD Patients | University of Palermo | Not applicable | Recruiting | Non Celiac Wheat Sensitivity, IBS (Irritable Bowel Syndrome), Functional Dyspepsia, Celiac Disease | 600 | Italy | clinicaltrials.gov |
| May 13, 2026 | NCT07584278 | Probiotics and Biomarkers in Irritable Bowel Syndrome | Sahlgrenska University Hospital | Not applicable | Recruiting | Irritable Bowel Syndrome (IBS) | 252 | Sweden | clinicaltrials.gov |
| May 12, 2026 | NCT07581756 | Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial | The First Affiliated Hospital of Soochow University | Not applicable | Recruiting | Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation... | 46 | China | clinicaltrials.gov |
| May 8, 2026 | NCT07576634 | Effects of Standardized Boswellia Carterii Extract on Irritable Bowel Syndrome Patients | Mansoura University | Phase 2/3 | Completed | Irritable Bowel Syndrome | 60 | Egypt | clinicaltrials.gov |
| May 1, 2026 | NCT07560345 | Effect of Neurodynamic Mobilization of Vagus Nerve on Irritable Bowel Syndrome in Women | Cairo University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 32 | Egypt | clinicaltrials.gov |
| April 22, 2026 | NCT07545772 | A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C) | Eli Lilly and Company | Phase 2 | Recruiting | Irritable Bowel Syndrome, Constipation | 342 | Belgium, Canada, China, Japan, Mexico, Spain, United Kingdom, United States | clinicaltrials.gov |
| April 22, 2026 | NCT07545759 | A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) | Eli Lilly and Company | Phase 2 | Recruiting | Irritable Bowel Syndrome, Diarrhea | 531 | Belgium, Canada, China, Germany, Japan, Mexico, Poland, Spain, United Kingdom... | clinicaltrials.gov |
| April 21, 2026 | NCT07543354 | Personalized Therapy of Long-term Low FODMAP in IBS Treatment: Role of Mobile Application and "Microbiota-gut-brain" Axis | Taipei Veterans General Hospital, Taiwan | Not applicable | Not yet recruiting | IBS - Irritable Bowel Syndrome | 200 | Taiwan | clinicaltrials.gov |
| April 20, 2026 | NCT07540312 | A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome | PGP Health | Not applicable | Recruiting | IBS (Irritable Bowel Syndrome) | 20 | United States | clinicaltrials.gov |
| April 20, 2026 | NCT07539077 | Prevalence of Disorders of Gut-Brain-Interaction in Pediatric Patients With In-remission Inflammatory Bowel Disease | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Completed | IBD (Inflammatory Bowel Disease), IBS (Irritable Bowel Syndrome) | 220 | Italy | clinicaltrials.gov |
| April 20, 2026 | NCT07539051 | Psychoemotional Status and Functional Gastrointestinal Disorders | Center of New Medical Technologies | Observational | Not yet recruiting | Functional Dyspepsia, Irritable Bowel Syndrome | 150 | Russia | clinicaltrials.gov |
| April 16, 2026 | NCT07534930 | Personalised Multidisciplinary Treatment in Moderate to Severe IBS | Linkoeping University | Not applicable | Active not recruiting | IBS (Irritable Bowel Syndrome), DGBI | 150 | Sweden | clinicaltrials.gov |
| April 16, 2026 | NCT07533500 | Effect of Autogenic Relaxation Training on Irritable Bowel Syndrome In Adult Females | Cairo University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 44 | Egypt | clinicaltrials.gov |
| April 13, 2026 | NCT07522255 | Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders | Mahidol University | Phase 3 | Not yet recruiting | Bloating, Rifaximin, Functional Bowel Disorder, Irritable Bowel Syndrome, Constipation, Microbiota, Metabolomic Profile | 78 | Thailand | clinicaltrials.gov |
| April 9, 2026 | NCT07519395 | A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D)... | GlaxoSmithKline | Phase 2 | Recruiting | Irritable Bowel Syndrome | 420 | United States | clinicaltrials.gov |
| April 8, 2026 | NCT07517029 | Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | IBS - Irritable Bowel Syndrome, Post Infection Syndrome | 315 | Italy | clinicaltrials.gov |
| March 27, 2026 | NCT07494968 | Defining Objective Markers of Compliance for Dietary Therapies in IBS | University of Michigan | Not applicable | Recruiting | Irritable Bowel Syndrome | 94 | United States | clinicaltrials.gov |
| March 20, 2026 | NCT07484412 | Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms | Seoul National University Bundang Hospital | Not applicable | Active not recruiting | Lower Abdominal Pain, Diarrhea, Irritable Bowel Syndrome | 88 | South Korea | clinicaltrials.gov |
| March 18, 2026 | NCT07481422 | Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome | University of Rijeka | Phase 1/2 | Recruiting | Irritable Bowel Syndrome (IBS) | 70 | Croatia | clinicaltrials.gov |
| March 16, 2026 | NCT07475299 | Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 8 | Romania | clinicaltrials.gov |
| March 13, 2026 | NCT07471490 | Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable... | DiaSorin Inc. | Observational | Enrolling by invitation | IBD (Inflammatory Bowel Disease), IBS (Irritable Bowel Syndrome), Gastrointestinal Symptoms | 300 | Italy, United States | clinicaltrials.gov |
| March 12, 2026 | NCT07467278 | Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome | Istanbul Medipol University Hospital | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 24 | clinicaltrials.gov | |
| March 12, 2026 | NCT07465562 | Galactol® Enzyme Supplement for Post-Prandial Abdominal Bloating in Irritable Bowel Syndrome | Liaquat University of Medical & Health Sciences | Not applicable | Completed | Irritable Bowel Syndrome, Abdominal Bloating | 300 | Italy | clinicaltrials.gov |
| February 27, 2026 | NCT07436910 | Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease | Cairo University | Observational | Enrolling by invitation | Irritable Bowel Disease, Ulcerative Colitis (UC), Crohn Disease (CD) | 385 | Egypt | clinicaltrials.gov |
| February 25, 2026 | NCT07431957 | "Efficacy and Safety of Linaclotide in Chronic Constipation" | Md Mehedi Shahriar | Phase 4 | Not yet recruiting | Chronic Idiopathic Constipation, Irritable Bowel Syndrome (IBS-C), Chronic Constipation, CIC, Constipation Predominant... | 90 | Bangladesh | clinicaltrials.gov |
| February 20, 2026 | NCT07425145 | Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study | First People's Hospital of Foshan | Not applicable | Not yet recruiting | IBS, Diarrhea Predominant | 200 | China | clinicaltrials.gov |
| February 20, 2026 | NCT07424898 | Lactose Intolerance and Intestinal Permability | Bezmialem Vakif University | Observational | Enrolling by invitation | Lactose Intolerance, Adult Type, Intestinal Permability, IBS (Irritable Bowel Syndrome) | 200 | Turkey (Türkiye) | clinicaltrials.gov |
| February 19, 2026 | NCT07421011 | Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in... | Valenta Pharm JSC | Phase 1 | Recruiting | Irritable Bowel Syndrome, Gallstone Disease, GERD, Biliary Dyskinesia, Postcholecystectomy Syndrome | 36 | Russia | clinicaltrials.gov |
| February 9, 2026 | NCT07397533 | Effects of Aerobic Exercise and Pain Neuroscience Education in Irritable Bowel Syndrome | Istinye University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 33 | Turkey (Türkiye) | clinicaltrials.gov |
| January 22, 2026 | NCT07360938 | Drug Interaction Potential of Pro-Inflammatory Conditions | Indiana University | Observational | Recruiting | Diabetes Mellitus, Type 2, End Stage Renal Disease, Irritable Bowel Syndrome | 150 | United States | clinicaltrials.gov |
| January 15, 2026 | NCT07345377 | Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel... | The Affiliated Hospital of Hangzhou Normal University | Not applicable | Enrolling by invitation | Irritable Bowel Syndrome (IBS), Pain, Depressive Disorder, Major, Moderate | 160 | China | clinicaltrials.gov |
| January 13, 2026 | NCT07337707 | New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome. | University Hospital, Rouen | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 60 | France | clinicaltrials.gov |
| January 6, 2026 | NCT07319078 | Pain in Pediatric Patients - Internet Interventions for Disorders of Gut-brain Interaction | Karolinska Institutet | Not applicable | Recruiting | Irritable Bowel Disease, Functional Abdominal Pain - Not Otherwise Specified (FAP-NOS), Functional Dyspepsia | 200 | Sweden | clinicaltrials.gov |
| December 30, 2025 | NCT07309601 | Sucrase-Isomaltase (SI) Genes and Meal Load | Region Skane | Not applicable | Recruiting | IBS - Irritable Bowel Syndrome, Sucrase-Isomaltase Deficiency | 70 | Sweden | clinicaltrials.gov |
| December 23, 2025 | NCT07299305 | (FODMAP) Diet on Improving Symptoms of Patients With Irritable Bowel Syndrome | Zagazig University | Not applicable | Completed | Irritable Bowel Disease | 183 | Egypt | clinicaltrials.gov |
| December 15, 2025 | NCT07283341 | Diet and Motility in IBS | Children's Hospital of Philadelphia | Observational | Recruiting | Irritable Bowel Syndrome (IBS) | 90 | United States | clinicaltrials.gov |
| December 3, 2025 | NCT07261826 | Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics | Chen QiYi | Observational | Recruiting | Clostridium Difficile Infection Recurrence, Ulcerative Colitis (UC), Crohn Disease (CD), Irritable Bowel Syndrome... | 4,000 | China | clinicaltrials.gov |
| December 1, 2025 | NCT07256262 | Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C) | Beni-Suef University | Not applicable | Not yet recruiting | Irritable Bowel Syndrome | 50 | Egypt | clinicaltrials.gov |
| November 25, 2025 | NCT07247994 | Neurological Manifestations in Children Diagnosed With Inflammatory Bowel Disease | Bishoy Shehata Fahim | Observational | Not yet recruiting | IBD (Inflammatory Bowel Disease) | 44 | clinicaltrials.gov | |
| November 20, 2025 | NCT07238790 | Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea | Stanford University | Early phase 1 | Not yet recruiting | IBS (Irritable Bowel Syndrome), Diarrhea | 13 | United States | clinicaltrials.gov |
| November 19, 2025 | NCT07235228 | Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients | The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz | Not applicable | Recruiting | Irritable Bowel Syndrome | 20 | Poland | clinicaltrials.gov |
| November 19, 2025 | NCT07235215 | Vivatlac in Irritable Bowel Syndrome II (ViIBS2) | The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz | Not applicable | Recruiting | Irritable Bowel Syndrome | 200 | Poland | clinicaltrials.gov |
| October 30, 2025 | NCT07222943 | Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children | Baylor College of Medicine | Not applicable | Recruiting | Functional Abdominal Pain Disorders, Irritable Bowel Syndrome (IBS), Functional Gastrointestinal Disorders (FGIDs)... | 63 | United States | clinicaltrials.gov |
| October 14, 2025 | NCT07216092 | Audio-recorded Gut-Hypnotherapy for Sleep and Pain in Pediatric Abdominal Pain Disorders | Children's Hospital at Montefiore | Not applicable | Completed | Irritable Bowel Syndrome, Disorders of Gut-brain Interaction | 46 | United States | clinicaltrials.gov |
| October 8, 2025 | NCT07212569 | Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy... | Zhongshan Hospital Xiamen University | Observational | Not yet recruiting | Irritable Bowel Syndrome | 90 | China | clinicaltrials.gov |
| September 16, 2025 | NCT07176078 | Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome | Universitair Ziekenhuis Brussel | Not applicable | Recruiting | Irritable Bowel Syndrome (IBS), Fibromyalgia (FM) | 96 | Belgium | clinicaltrials.gov |
| September 15, 2025 | NCT07172581 | Online Low-FODMAP Diet in Irritable Bowel Syndrome | Centre hospitalier de l'Université de Montréal (CHUM) | Not applicable | Completed | Irritable Bowel Syndrome | 40 | Canada | clinicaltrials.gov |
| September 15, 2025 | NCT07172139 | Transcranial Magnetic Stimulation and Pharmacologic/Probiotic Interventions for Diarrhea-Predominant IBS | Rui Li | Not applicable | Not yet recruiting | IBS (Irritable Bowel Syndrome) | 140 | clinicaltrials.gov | |
| September 11, 2025 | NCT07168434 | Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome | Biocodex | Phase 3 | Recruiting | IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant), IBS, Mixed Symptoms | 406 | Portugal, Spain | clinicaltrials.gov |
| September 2, 2025 | NCT07149519 | Impact of Dietary Guidance and Probiotics in the Treatment of Endometriosis and Irritable Bowel Syndrome in Women | University of Sao Paulo | Not applicable | Recruiting | Endometriosis, Bowels Irritable | 74 | Brazil | clinicaltrials.gov |
| August 28, 2025 | NCT07145580 | Combined Lactulose H2-breath Test With Abdominal Imaging | Klinik Arlesheim | Observational | Completed | Food Intolerance Syndromes, Small Intestinal Bacterial Overgrowth Syndrome (SIBO), Breath Tests | 510 | Switzerland | clinicaltrials.gov |
| August 15, 2025 | NCT07125625 | Probiotic Mixture (L. Rhamnosus GG and L. Plantarum 299V) In Pediatric Irritable Bowel Syndrome | University of Bari | Not applicable | Recruiting | Irritable Bowel Syndrome (IBS) | 124 | Italy | clinicaltrials.gov |
| August 5, 2025 | NCT07103772 | Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome | Universidad Autonoma de Nuevo Leon | Not applicable | Enrolling by invitation | Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome With Constipation, Irritable... | 94 | Mexico | clinicaltrials.gov |
| July 28, 2025 | NCT07089420 | ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects | American Laboratory Products Company | Observational | Completed | IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, Crohn Disease (CD), UC - Ulcerative Colitis | 121 | United States | clinicaltrials.gov |
| July 8, 2025 | NCT07052890 | Curcumin, Vitamin D and Green Tea in IBS-D | Dr Anthony Hobson | Not applicable | Completed | Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D) | 78 | United Kingdom | clinicaltrials.gov |
| July 4, 2025 | NCT07051226 | Deep Learning-Based Confocal Laser Microendoscopy Feature Atlas Construction and Its Application in Intelligent Diagnosis of Irritable... | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Observational | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 90 | clinicaltrials.gov | |
| June 26, 2025 | NCT07039747 | Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome | University Hospital, Rouen | Phase 2 | Recruiting | Irritable Bowel Syndrome | 100 | France | clinicaltrials.gov |
| June 24, 2025 | NCT07033936 | Prevalence of Irritable Bowel Syndrome Among Egyptian Medical Students | Zagazig University | Observational | Completed | Irritable Bowel Syndrome | 1,093 | Egypt | clinicaltrials.gov |
| June 11, 2025 | NCT07016529 | Diagnostic Study for Differentiating Functional From Organic Diseases in Patients With Lower GIT Symptoms | Sohag University | Observational | Not yet recruiting | Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) | 100 | clinicaltrials.gov | |
| June 6, 2025 | NCT07008404 | Feasibility of an Online Cognitive Behavioural Therapy Application (Mahana IBS™, Mahana Therapeutics) in the Management of Irritable Bowel... | Nottingham University Hospitals NHS Trust | Not applicable | Terminated | Irritable Bowel Syndrome (IBS) | 20 | United Kingdom | clinicaltrials.gov |
| June 2, 2025 | NCT07000383 | Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome | University Medical Center Ho Chi Minh City (UMC) | Not applicable | Recruiting | Diarrhea-predominant Irritable Bowel Syndrome, Irritable Bowel Syndrome of Diarrhea Type (IBS-D) | 90 | Vietnam | clinicaltrials.gov |
| June 2, 2025 | NCT07000227 | Mechanism of FODMAP Restriction on FGID Patients | Universiti Kebangsaan Malaysia Medical Centre | Not applicable | Recruiting | Functional Gastrointestinal Disorders (FGIDs), Irritable Bowel Syndrome (IBS), Functional Dyspepsia | 60 | Malaysia | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Cairo University | 7 | August 12, 2026 |
| Stanford University | 3 | October 5, 2026 |
| The First Affiliated Hospital of Soochow University | 3 | May 12, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 | April 20, 2026 |
| University Hospital, Rouen | 3 | January 13, 2026 |
| University of Palermo | 2 | August 6, 2026 |
| Beijing Tiantan Hospital | 2 | June 9, 2026 |
| Sahlgrenska University Hospital | 2 | May 26, 2026 |
| Eli Lilly and Company | 2 | April 22, 2026 |
| Mahidol University | 2 | April 13, 2026 |
| Zagazig University | 2 | December 23, 2025 |
| The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz | 2 | November 19, 2025 |
| Attikon Hospital | 2 | April 6, 2025 |
| Mayo Clinic | 2 | March 3, 2025 |
| Yale University | 2 | February 26, 2025 |
| University of California, Los Angeles | 1 | November 9, 2026 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 | November 6, 2026 |
| University of Roehampton | 1 | November 4, 2026 |
| Szeged University | 1 | November 4, 2026 |
| Aziz Bhatti Shaheed Teaching Hospital | 1 | November 3, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 99 | November 9, 2026 |
| Observational | 26 | November 6, 2026 |
| Phase 2 | 7 | August 17, 2026 |
| Phase 1 | 4 | October 20, 2026 |
| Early phase 1 | 3 | November 20, 2025 |
| Phase 3 | 2 | April 13, 2026 |
| Phase 2/3 | 1 | May 8, 2026 |
| Phase 1/2 | 1 | March 18, 2026 |
| Phase 4 | 1 | February 25, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 31 | November 9, 2026 |
| Italy | 12 | November 6, 2026 |
| China | 12 | June 15, 2026 |
| Turkey (Türkiye) | 11 | October 13, 2026 |
| Egypt | 11 | September 1, 2026 |
| United Kingdom | 6 | November 4, 2026 |
| Canada | 6 | October 20, 2026 |
| Poland | 5 | August 28, 2026 |
| Sweden | 5 | May 26, 2026 |
| Belgium | 4 | June 17, 2026 |
| Russia | 4 | April 20, 2026 |
| France | 4 | January 13, 2026 |
| Mexico | 3 | April 22, 2026 |
| Spain | 3 | April 22, 2026 |
| Malaysia | 2 | July 13, 2026 |
| Vietnam | 2 | June 18, 2026 |
| Japan | 2 | April 22, 2026 |
| Germany | 2 | April 22, 2026 |
| South Korea | 2 | March 20, 2026 |
| Greece | 2 | April 6, 2025 |
| India | 2 | March 21, 2025 |
| Hungary | 1 | November 4, 2026 |
| Pakistan | 1 | November 3, 2026 |
| Taiwan | 1 | April 21, 2026 |
| Thailand | 1 | April 13, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.